Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway Medical Countermeasures June 1, 2021 …
2021 BAA for Development of Medical Countermeasures for Biological Threats Contracts + Grants March 2, 2021 …
Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity Contracts + Grants November 25, 2020 …
Scent of a Virus: NIH Seeks Novel Tech to Detect COVID-19 From Skin Odors Biodetection September 7, 2020 …
NIAID Establishes New Global Network to Focus on Spillover Potential of Emerging Diseases Biosecurity August 27, 2020 …
Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial Medical Countermeasures July 14, 2020 …
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding Contracts + Grants May 7, 2020 …
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Medical Countermeasures March 19, 2020 …
Government Issues Urgent Competitive Revision to Existing NIH Grants to Support COVID-19 Response Contracts + Grants February 6, 2020 …
Emory University to Lead Infectious Diseases Clinical Research Consortium Leadership Group Medical Countermeasures January 3, 2020 …
Re-compete: CEIRR Influenza Data Processing and Communication Center (iDPCC) Contracts + Grants November 13, 2019 …
Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core Contracts + Grants September 20, 2019 …
Senate Funding Bills Recognize, but Fall Short of Needs for Critical Infectious Disease Responses Policy + Initiatives September 19, 2019 …